Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Nockchain Nockchain +22.61%
#4 Fabric Protocol Fabric Protocol +19.38%
#5 Bedrock Bedrock +16.78%
#6 Cysic Cysic +15.00%
#7 Perle Perle +12.14%
#8 Tutorial Tutorial +6.24%
#9 Anvil Anvil +6.20%
#10 Arowana Arowana +6.03%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Classificação em ações #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Preço da ação
$0.07
Última sincronização: 2024-11-12
Valor de mercado
$1.62M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Peak Bio, Inc. (PKBO)

Categoria

Healthcare
EPS de Peak Bio, Inc. (PKBO)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Peak Bio, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Peak Bio, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE